US-based pharmaceutical company is dedicated to transforming the treatment of iron deficiency and anemia
Bethesda, MD – The Medical Technology and Practice Patterns Institute (MTPPI – mtppi.org) announced that Rockwell Medical has agreed to serve as the Conference Welcome Sponsor for the National Symposium on Anemia Renal Research ( www.RenalAnemiaResearch.org ). “Rockwell Medical has been working to improve outcomes for patients with Chronic Kidney Disease and End-Stage Renal Disease for the last twenty-five years,” said Nicholas Hamilton-Cotter, Director of Development and Strategic Alliances at MTPPI. “It has been a pleasure working with Gina DeSalvo-Tilton and her team as we develop the best patient engagement experience possible for the Symposium”
About Rockwell Medical: Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. Triferic, available for use in the U.S., is the company’s leading FDA-approved iron maintenance therapy to keep dialysis patient’s hemoglobin in balance. As an established manufacturer and leader in delivering high-quality, innovative drug therapies and hemodialysis concentrates to dialysis providers and distributors in the U.S. and abroad, Rockwell provides products used to save and sustain human life, removing toxins and replacing critical nutrients in the dialysis patient’s bloodstream. Our life-sustaining products are not considered discretional in nature nor their use capable of being deferred.
About the Patient Research Agenda for Improved Kidney Care Outcomes (PRAIKCO) National Symposium: The National Symposium weekend ( www.RenalAnemiaResearch.org ) is the culmination of a two-year long initiative led by the Medical Technology and Practice Patterns Institute. The goal of the Symposium weekend is to compile an integrated list of research priorities and potential strategies to improve dialysis care in real-world, clinical settings. Attendees will give recommendations for research questions while working towards consensus on priority topics, research design considerations, data collection strategies, reporting and dissemination channels, anemia management policy making opportunities, and patient education strategies. Final deliverables will be used to inform future research, policy, and clinical practice.
About the Medical Technology and Practice Patterns Institute, Inc. (MTPPI): Medical Technology and Practice Patterns Institute (MTPPI – mtppi.org) is a nonprofit organization established in 1986 to conduct research on the clinical and economic implications of health care technologies. MTPPI’s research is directed toward the formulation and implementation of local and national health care policies. With extensive investigator experience in both the public and private sectors, MTPPI’s staff designs, implements, and conducts a full range of healthcare research and technology development activities. Our staff includes statisticians, epidemiologists, economists, programmers, biomedical engineers, and policy analysts. We specialize in using big data to conduct “real-time”, “real-world” studies that are both affordable and useful for healthcare stakeholders.
Comments